510(k) K960871

SPECTROLYSE ANTITHROMBIN III (ANTI-XA) by Medical Diagnostic Technologies, Inc. — Product Code JBQ

K960871 is an FDA 510(k) premarket notification submitted by Medical Diagnostic Technologies, Inc. for the device "SPECTROLYSE ANTITHROMBIN III (ANTI-XA)". The FDA issued a decision of Substantially Equivalent on August 14, 1996. The device falls under product code JBQ (Antithrombin Iii Quantitation), a Class II device regulated under 21 CFR 864.7060. Medical Diagnostic Technologies, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 14, 1996
Date Received
March 4, 1996
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antithrombin Iii Quantitation
Device Class
Class II
Regulation Number
864.7060
Review Panel
HE
Submission Type